P930021/S034: Straumann Emdogain
FDA’s recorded scope: implementation of new Blue zone cleanroom area (ISO 7/8)
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 1 FDA record to the applicant name The Straumann Company. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 5, 2025 to Sep 5, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code NQA appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P930021, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 60 Minuteman Rd., Andover, MA, 01810. Recorded on P930021/S034, decision dated Sep 5, 2025.
FDA’s recorded scope: implementation of new Blue zone cleanroom area (ISO 7/8)
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Straumann EmdogainP930021/S034 | The Straumann Company | PMA supplement | Sep 5, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.